Benitec Says USPTO Poised to Finalize Validity Ruling for Key Patent
February 17, 2011
Benitec Says USPTO Poised to Finalize Validity Ruling for Key Patent
Although it was one of the earliest patents in the RNAi field, the IP had earlier been deemed invalid by the USPTO after re-examination proceedings were initiated by now-defunct expressed RNAi firm Nucleonics.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Benitec Wins US Patent Allowance, Says Separate IP Re-exam Likely to Extend into Late 2010
September 3, 2009 / Gene Silencing News - Benitec Looks to Outlicense IP While Avoiding Litigation Mistakes of Its Past
November 8, 2012 / Gene Silencing News - Re-Exam of Benitec US Patent Ends, Company Hits Opposition in UK
November 11, 2010 / Gene Silencing News - Benitec Says USPTO Reverses Rejection of US Patent
September 30, 2010 / Gene Silencing News - Patents Held by Benitec, Collaborator Allowed in US, South Korea, China
April 4, 2013 / Gene Silencing News